Proteomics analysis of a novel compound

Cyclic RGD in breast carcinoma cell line MCF-7

Hsueh Fen Juan, I. Hsiu Wang, Tsui Chin Huang, Jia Je Li, Shui Tein Chen, Hsuan Cheng Huang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In studies of cell adhesion, migration, growth, differentiation, and apoptosis, synthetic peptides containing the RGD (Arg-Gly-Asp) motif have been extensively used as the inhibitors of integrin-ligand interactions. The RGD motif is an integral-recognition motif found in many ligands, so that the RGD-containing peptides can be used to probe integrin functions in various biological systems. A linear RGD is a tripeptide consisting of a flexible structure that makes the motifbind to its receptor with inefficient chelating affinity. Therefore, we designed a cyclic-RGD peptide (Tpa-RGDWPC, cRGD) with rigid skeleton to closely bind with its receptor. The cRGD was obtained by solid-phase peptide synthesis method using Rink amide resin. We showed that the cRGD exerts more potency than linear RGD on inhibiting cell growth of MCF-7 breast carcinoma cells. This stimulated us to question how cRGD inhibits cell growth of MCF-7 cells. Moreover, understanding what molecular mechanism underlies the effect that RGD motif exerts on MCF-7 cells is also of considerable importance. We used proteomics and bioinformatics to survey the global changes in proteins after cRGD treatment in MCF-7 cells. The classification of these proteins is shown according to the different biological processes in which they are involved. Most of the proteins that appear to be strongly influenced by cRGD treatment are involved in metabolism, cell growth, responsive to external stimulus, cell communication, reproduction and cell death. This is the first report which monitors the protein expression profile of MCF-7 cells in response to treatment with RGD-containing peptides in a time-course analysis. The clustering data indicated temporal patterns of altered protein expression that can be categorized into early, intermediate and late response proteins. These patterns of protein expression may be important for predicting its response to cRGD. In summary, these results provide a molecular explanation for the properties of cRGD in breast cancer cells and present a valuable in-depth description of their possible impact on breast cancer therapy.

Original languageEnglish
Pages (from-to)2991-3000
Number of pages10
JournalProteomics
Volume6
Issue number10
DOIs
Publication statusPublished - May 2006
Externally publishedYes

Fingerprint

Proteomics
MCF-7 Cells
Cells
Breast Neoplasms
Cell Line
Cell growth
Proteins
Peptides
Solid-Phase Synthesis Techniques
Growth
Integrins
Ligands
Biological Phenomena
Synthetic Chemistry Techniques
Cyclic Peptides
Flexible structures
Cell adhesion
Cell death
Biological systems
Bioinformatics

Keywords

  • Apoptosis
  • Cluster analysis
  • MCF-7
  • Solid-phase peptide synthesis

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Proteomics analysis of a novel compound : Cyclic RGD in breast carcinoma cell line MCF-7. / Juan, Hsueh Fen; Wang, I. Hsiu; Huang, Tsui Chin; Li, Jia Je; Chen, Shui Tein; Huang, Hsuan Cheng.

In: Proteomics, Vol. 6, No. 10, 05.2006, p. 2991-3000.

Research output: Contribution to journalArticle

Juan, Hsueh Fen ; Wang, I. Hsiu ; Huang, Tsui Chin ; Li, Jia Je ; Chen, Shui Tein ; Huang, Hsuan Cheng. / Proteomics analysis of a novel compound : Cyclic RGD in breast carcinoma cell line MCF-7. In: Proteomics. 2006 ; Vol. 6, No. 10. pp. 2991-3000.
@article{ea9851e642e849d9a125fc5920361b9e,
title = "Proteomics analysis of a novel compound: Cyclic RGD in breast carcinoma cell line MCF-7",
abstract = "In studies of cell adhesion, migration, growth, differentiation, and apoptosis, synthetic peptides containing the RGD (Arg-Gly-Asp) motif have been extensively used as the inhibitors of integrin-ligand interactions. The RGD motif is an integral-recognition motif found in many ligands, so that the RGD-containing peptides can be used to probe integrin functions in various biological systems. A linear RGD is a tripeptide consisting of a flexible structure that makes the motifbind to its receptor with inefficient chelating affinity. Therefore, we designed a cyclic-RGD peptide (Tpa-RGDWPC, cRGD) with rigid skeleton to closely bind with its receptor. The cRGD was obtained by solid-phase peptide synthesis method using Rink amide resin. We showed that the cRGD exerts more potency than linear RGD on inhibiting cell growth of MCF-7 breast carcinoma cells. This stimulated us to question how cRGD inhibits cell growth of MCF-7 cells. Moreover, understanding what molecular mechanism underlies the effect that RGD motif exerts on MCF-7 cells is also of considerable importance. We used proteomics and bioinformatics to survey the global changes in proteins after cRGD treatment in MCF-7 cells. The classification of these proteins is shown according to the different biological processes in which they are involved. Most of the proteins that appear to be strongly influenced by cRGD treatment are involved in metabolism, cell growth, responsive to external stimulus, cell communication, reproduction and cell death. This is the first report which monitors the protein expression profile of MCF-7 cells in response to treatment with RGD-containing peptides in a time-course analysis. The clustering data indicated temporal patterns of altered protein expression that can be categorized into early, intermediate and late response proteins. These patterns of protein expression may be important for predicting its response to cRGD. In summary, these results provide a molecular explanation for the properties of cRGD in breast cancer cells and present a valuable in-depth description of their possible impact on breast cancer therapy.",
keywords = "Apoptosis, Cluster analysis, MCF-7, Solid-phase peptide synthesis",
author = "Juan, {Hsueh Fen} and Wang, {I. Hsiu} and Huang, {Tsui Chin} and Li, {Jia Je} and Chen, {Shui Tein} and Huang, {Hsuan Cheng}",
year = "2006",
month = "5",
doi = "10.1002/pmic.200500435",
language = "English",
volume = "6",
pages = "2991--3000",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - Proteomics analysis of a novel compound

T2 - Cyclic RGD in breast carcinoma cell line MCF-7

AU - Juan, Hsueh Fen

AU - Wang, I. Hsiu

AU - Huang, Tsui Chin

AU - Li, Jia Je

AU - Chen, Shui Tein

AU - Huang, Hsuan Cheng

PY - 2006/5

Y1 - 2006/5

N2 - In studies of cell adhesion, migration, growth, differentiation, and apoptosis, synthetic peptides containing the RGD (Arg-Gly-Asp) motif have been extensively used as the inhibitors of integrin-ligand interactions. The RGD motif is an integral-recognition motif found in many ligands, so that the RGD-containing peptides can be used to probe integrin functions in various biological systems. A linear RGD is a tripeptide consisting of a flexible structure that makes the motifbind to its receptor with inefficient chelating affinity. Therefore, we designed a cyclic-RGD peptide (Tpa-RGDWPC, cRGD) with rigid skeleton to closely bind with its receptor. The cRGD was obtained by solid-phase peptide synthesis method using Rink amide resin. We showed that the cRGD exerts more potency than linear RGD on inhibiting cell growth of MCF-7 breast carcinoma cells. This stimulated us to question how cRGD inhibits cell growth of MCF-7 cells. Moreover, understanding what molecular mechanism underlies the effect that RGD motif exerts on MCF-7 cells is also of considerable importance. We used proteomics and bioinformatics to survey the global changes in proteins after cRGD treatment in MCF-7 cells. The classification of these proteins is shown according to the different biological processes in which they are involved. Most of the proteins that appear to be strongly influenced by cRGD treatment are involved in metabolism, cell growth, responsive to external stimulus, cell communication, reproduction and cell death. This is the first report which monitors the protein expression profile of MCF-7 cells in response to treatment with RGD-containing peptides in a time-course analysis. The clustering data indicated temporal patterns of altered protein expression that can be categorized into early, intermediate and late response proteins. These patterns of protein expression may be important for predicting its response to cRGD. In summary, these results provide a molecular explanation for the properties of cRGD in breast cancer cells and present a valuable in-depth description of their possible impact on breast cancer therapy.

AB - In studies of cell adhesion, migration, growth, differentiation, and apoptosis, synthetic peptides containing the RGD (Arg-Gly-Asp) motif have been extensively used as the inhibitors of integrin-ligand interactions. The RGD motif is an integral-recognition motif found in many ligands, so that the RGD-containing peptides can be used to probe integrin functions in various biological systems. A linear RGD is a tripeptide consisting of a flexible structure that makes the motifbind to its receptor with inefficient chelating affinity. Therefore, we designed a cyclic-RGD peptide (Tpa-RGDWPC, cRGD) with rigid skeleton to closely bind with its receptor. The cRGD was obtained by solid-phase peptide synthesis method using Rink amide resin. We showed that the cRGD exerts more potency than linear RGD on inhibiting cell growth of MCF-7 breast carcinoma cells. This stimulated us to question how cRGD inhibits cell growth of MCF-7 cells. Moreover, understanding what molecular mechanism underlies the effect that RGD motif exerts on MCF-7 cells is also of considerable importance. We used proteomics and bioinformatics to survey the global changes in proteins after cRGD treatment in MCF-7 cells. The classification of these proteins is shown according to the different biological processes in which they are involved. Most of the proteins that appear to be strongly influenced by cRGD treatment are involved in metabolism, cell growth, responsive to external stimulus, cell communication, reproduction and cell death. This is the first report which monitors the protein expression profile of MCF-7 cells in response to treatment with RGD-containing peptides in a time-course analysis. The clustering data indicated temporal patterns of altered protein expression that can be categorized into early, intermediate and late response proteins. These patterns of protein expression may be important for predicting its response to cRGD. In summary, these results provide a molecular explanation for the properties of cRGD in breast cancer cells and present a valuable in-depth description of their possible impact on breast cancer therapy.

KW - Apoptosis

KW - Cluster analysis

KW - MCF-7

KW - Solid-phase peptide synthesis

UR - http://www.scopus.com/inward/record.url?scp=33744472210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744472210&partnerID=8YFLogxK

U2 - 10.1002/pmic.200500435

DO - 10.1002/pmic.200500435

M3 - Article

VL - 6

SP - 2991

EP - 3000

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 10

ER -